Self-assessment Tool for Implementing the ESCNH

April 23, 2024 updated by: Luc Zimmermann, European Foundation for the Care of Newborn Infants

Hospital Self-assessment Tool for the Implementation of the European Standards of Care for Newborn Health (ESCNH)

This study aims to develop a tool for hospitals to self-assess the implementation of the European Standards of Care for Newborn Health (ESCNH), standards defining best-practice procedures for neonatal care. The tool shall support healthcare professionals across Europe to measure the level of implementation of the ESCNH, to identify variations in care delivery, and ultimately to improve neonatal care. To achieve this, healthcare professionals from all relevant backgrounds and parent representatives will be invited to take part in an electronic Delphi consensus approach. A subsequent pilot-testing among at least 10 hospitals across Europe will refine the developed tool, indicate potential errors, ensure user-friendliness, and improve the applicability.

Study Overview

Detailed Description

This project aims to develop a uniformly applicable self-assessment tool in different languages with the overall goal to support care providers across Europe to measure the level of implementation of the ESCNH, to pinpoint possible inhibitors, and ultimately to increase the extent of implementation. Covering the great variety of standards in one hands-on and easy-to-use self-assessment tool requires prioritising the most important components. This has to be approached in a systematic and scientific manner. For this purpose, a two-round electronic (e) Delphi survey will be conducted followed by an expert workshop. The aim of the two-stage eDelphi process is to lay a solid ground for the self-assessment tool. Prior to the eDelphi rounds, members of the study team together with the Project Expert Group (PEG) will condense and prioritise the ESCNH into one online questionnaire and thereby elaborate the first framework of the self-assessment tool. Next to participant-related information such as profession or country of employment, the questionnaire will cover specific aspects of the eleven major topics of the ESCNH namely: Birth and transfer, medical care and clinical practice, care procedures, infant- and family-centred developmental care, neonatal intensive care unit (NICU) design, nutrition, ethical decision-making and palliative care, follow-up and continuing care, patient safety and hygiene practice, data collection and documentation, education and training. The questionnaire will subsequently, in the first eDelphi round, be evaluated by the eDelphi panel. The panel consist of approximately 100 healthcare professionals from various disciplines related to neonatal care as well as parent representatives. In the first eDelphi round, panellists will appraise the relevance of included content, the wording of questions as well as the prioritisation of content to be included in the self-assessment tool. This will be enabled through a predefined evaluation scheme as well as free-text fields. Based on feedback from panellists, the preliminary self-assessment tool will be adapted by adding additional information, removing unnecessary items and re-wording if necessary. In the subsequent (second) eDelphi round, the same panellists will receive qualitative and quantitative information on the adaptation of the first version and will have again the option to evaluate the adapted questionnaire. Remaining discrepancies will be discussed in a final consensus workshop. For this purpose, 20-30 panellists will be selected based on their level of experience and invited for participation. The result of the workshop will be the agreed-upon content for the self-assessment tool. Except for the workshop, data collection during the eDelphi rounds will be anonymous.

To ensure applicability, the self-assessment tool will be pilot tested in European hospitals. For this purpose, the self-assessment tool will be translated into 5 languages (German, French, Italian, Swedish, Portuguese, and Spanish). For the pilot-testing, healthcare professionals in 10 pilot hospitals across Europe will be invited to evaluate the self-assessment tool. Feedback of the pilot-testing will be discussed with the PEG and adapted accordingly.

Study Type

Observational

Enrollment (Estimated)

100

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Bavaria
      • Munich, Bavaria, Germany, 81379
        • European Foundation for the Care of Newborn Infants (EFCNI)
        • Contact:
        • Contact:
        • Principal Investigator:
          • Luc Zimmermann, Prof.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

The PEG consists of 8 renowned experts of multidisciplinary professions: neonatologists, a (neonatal) nurses, an obstetrician, a parent representative, a public health expert, and a statistician and is completed by members of the EFCNI study team.

The eDelphi panels will consist of experts from various European countries from the following fields: neonatology, midwifery, (neonatal) care, obstetrics, parent representing institutions, psychology, and physiotherapy.

Participants for the pilot-testing will be healthcare professionals with varying professional backgrounds in pilot hospitals across Europe.

Description

Inclusion criteria Participants will be eligible if they are

  • parent representatives or representatives of caregivers of infants who received special/intensive care,
  • healthcare professionals in the field of neonatology, midwifery, neonatal nursing care, obstetrics, psychology, health sociology, physical therapy, or
  • hospital management.

Exclusion Criteria Participants will be excluded if they

  • provide insufficient proficiency of English for the eDelphi questionnaires or the languages of the self-assessment tool in the pilot testing, or
  • have a professional background that is not related to the ESCNH / individuals that are not parent representatives or representatives of caregiver of infants who received special/intensive care.
  • primarily work in the industry.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
eDelphi panel/participants
The eDelphi panels will consist of approximately 100 healthcare professionals from various European countries from the following fields: neonatology, midwifery, (neonatal) care, obstetrics, parent representing institutions, psychology, and physiotherapy. 20-30 of them will be invited for a final consensus workshop.
Please note that this is an observational study; not applicable
Pilot hospitals
10 hospitals with neonatal units from Germany, UK, France, Italy, Sweden, Portugal, and Spain.
Please note that this is an observational study; not applicable

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Online self-assessment tool (including statements and questions)
Time Frame: 15.06.2024 - 15.07.2025
Within a two-round eDelphi survey, the eDelphi panel will critically appraise the first template of the self-assessment tool. If required (indicated by ≥ 80% of participants) additional items will be added or unnecessary items will be removed. Remaining discrepancies will be discussed in a final consensus workshop and the questionnaire will be adapted based on consensus gathered within the workshop. The resulting questionnaire will be the first version of the self-assessment tool, which will be evaluated during and adapted after a pilot-testing phase.
15.06.2024 - 15.07.2025

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Response rates
Time Frame: 15.10.2024 - 30.06.2025
Number of participants completing the first and second eDelphi round, number of hospitals joining the pilot-testing phase
15.10.2024 - 30.06.2025
Demographics and characteristics
Time Frame: 15.10.2024 - 30.06.2025
A summary of demographic information and the participants characteristics will be presented
15.10.2024 - 30.06.2025
User-friendliness score of the self-assessment tool
Time Frame: 15.10.2024 - 30.06.2025
Time taken to fill in, illustration on screen, understandability
15.10.2024 - 30.06.2025
Applicability score of the formulation of the questions
Time Frame: 15.10.2024 - 30.06.2025
Evaluation data on formulation of the questions and understandability
15.10.2024 - 30.06.2025
Qualitative feedback on illustration of output
Time Frame: 15.10.2024 - 30.06.2025
Evaluation data on illustration of questionnaire on the screen
15.10.2024 - 30.06.2025
Appraisal on the utilisation of the self-assessment tool
Time Frame: 15.10.2024 - 30.06.2025
Evaluation data on the utilisation of the self-assessment tool
15.10.2024 - 30.06.2025
Scalability of the self-assessment tool and dissemination
Time Frame: 15.10.2024 - 30.06.2025
Evaluation data on the usage and outreach
15.10.2024 - 30.06.2025

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Silke Mader, European Foundation for the Care of Newborn Infants
  • Study Director: Julia Hoffmann, Dr., European Foundation for the Care of Newborn Infants

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

June 3, 2024

Primary Completion (Estimated)

October 1, 2025

Study Completion (Estimated)

September 1, 2026

Study Registration Dates

First Submitted

April 18, 2024

First Submitted That Met QC Criteria

April 18, 2024

First Posted (Actual)

April 23, 2024

Study Record Updates

Last Update Posted (Actual)

April 25, 2024

Last Update Submitted That Met QC Criteria

April 23, 2024

Last Verified

April 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Study Data/Documents

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Self-Assessment

Clinical Trials on Please note that this is an observational study; not applicable

Subscribe